AF
Finckh, Axel
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Rhumatismes inflammatoires : où en est-on avec les JAK-inhibiteurs ? | Rheuma Plus / Schweiz |  | 2025 | 1 | 0 | ||
| Reply | Arthritis & rheumatology |  | 2025 | 2 | 0 | ||
| Antibiotics in inflammatory arthritis and background population one year before and after diagnosis : a nationwide drug utilization study | Rheumatology | | 2025 | 1 | 0 | ||
| When borders impact science : what is the future of European rheumatology research ? | Annals of the rheumatic diseases | | 2025 | 1 | 0 | ||
| Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors compared to biologic disease-modifying antirheumatic drugs : data from an international collaboration of registries (the "JAK-pot" study) | Arthritis & rheumatology | | 2025 | 77 | 33 | ||
| Antirheumatic drugs in reproduction, pregnancy, and lactation : a systematic literature review informing the 2024 update of the EULAR recommendations | Annals of the rheumatic diseases | | 2025 | 16 | 32 | ||
| The epidemiology of RA | Nature reviews. Rheumatology | | 2025 | 1 | 0 | ||
| Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer | Annals of the rheumatic diseases | | 2025 | 42 | 0 | ||
| Rhumatologie : ce qui a changé en 2023 | Revue médicale suisse | | 2024 | 45 | 22 | ||
| Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index : a cohort study in a Swiss registry | BMJ open | | 2024 | 1 | 0 | ||
| Rotation or change of biotherapy after TNF blocker treatment failure for axial spondyloarthritis : the ROC-SpA study, a randomised controlled study protocol | BMJ open | | 2024 | 1 | 2 | ||
| Gut microbiome and intestinal inflammation in preclinical stages of rheumatoid arthritis | RMD open | | 2024 | 101 | 35 | ||
| Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the ‘JAK-pot’ study) | Annals of the rheumatic diseases | | 2024 | 90 | 55 | ||
| Explainable deep learning for disease activity prediction in chronic inflammatory joint diseases | PLOS digital health | | 2024 | 1 | 0 | ||
| Anti-apolipoprotein A-1 IgG, incident cardiovascular events, and lipid paradox in rheumatoid arthritis | Frontiers in cardiovascular medicine | | 2024 | 110 | 128 | ||
| Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RA | BMJ open | | 2024 | 130 | 54 | ||
| Tofacitinib Monotherapy in Rheumatoid Arthritis : Clinical Trials and Real-World Data Contextualization of Patients, Efficacy, and Treatment Retention | Open access rheumatology | | 2024 | 1 | 0 | ||
| Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies | Joint bone spine | | 2024 | 97 | 61 | ||
| 2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer | Annals of the rheumatic diseases | | 2024 | 52 | 160 | ||
| Concomitant Sjögren's disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss clinical quality management cohort | Arthritis research & therapy | | 2024 | 1 | 0 | ||
| Brief report: can COVID-19 infection trigger rheumatoid arthritis-associated autoimmunity in individuals at risk for the disease? A nested cohort study | Frontiers in medicine | | 2023 | 62 | 59 | ||
| Longitudinal associations between body mass index and changes in disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab | RMD open | | 2023 | 81 | 22 | ||
| The Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: predicting clinical arthritis development | Scandinavian journal of rheumatology | | 2023 | 144 | 85 | ||
| A potential role for chlamydial infection in rheumatoid arthritis development | Rheumatology | | 2023 | 88 | 117 | ||
| Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy | Rheumatology | | 2023 | 76 | 93 | ||
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update | Annals of the rheumatic diseases | | 2023 | 249 | 185 | ||
| Characterization of serum biomarkers and antibody responses against Prevotella spp. in preclinical and new-onset phase of rheumatic diseases | Frontiers in cellular and infection microbiology | | 2023 | 106 | 54 | ||
| Brief report : assessment of mucosal barrier integrity using serological biomarkers in preclinical stages of rheumatoid arthritis | Frontiers in immunology | | 2023 | 181 | 161 | ||
| Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries | Arthritis research & therapy | | 2023 | 65 | 84 | ||
| Impact of SARS-CoV2 infection on anti-apolipoprotein A-1 IgG response in inflammatory rheumatic diseases | Frontiers in immunology | | 2023 | 128 | 71 | ||
| Management of giant-cell arteritis in Switzerland: an online national survey | Swiss medical weekly | | 2023 | 227 | 138 | ||
| Omicron-specific cytotoxic t-cell responses after a third dose of mrna covid-19 vaccine among patients with multiple sclerosis treated with ocrelizumab | JAMA neurology | | 2022 | 242 | 148 | ||
| EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology | Annals of the rheumatic diseases | | 2022 | 207 | 66 | ||
| After JAK inhibitor failure: to cycle or to switch, that is the question – data from the JAK-pot collaboration of registries | Annals of the rheumatic diseases | | 2022 | 263 | 363 | ||
| Nouveautés en médecine 2021 - Rhumatologie | Revue médicale suisse | | 2022 | 290 | 183 | ||
| Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study | Annals of the rheumatic diseases | | 2022 | 290 | 106 | ||
| Periodontitis in first degree-relatives of individuals with rheumatoid arthritis: a short narrative review | Frontiers in oral health | | 2022 | 198 | 75 | ||
| Prévention vaccinale chez les patients avec des maladies rhumatismales | Revue médicale suisse | | 2022 | 108 | 92 | ||
| Lower odds of remission among women with rheumatoid arthritis: A cohort study in the Swiss Clinical Quality Management cohort | PloS one | | 2022 | 69 | 28 | ||
| Combining individual patient data from randomized and non-randomized studies to predict real-world effectiveness of interventions | Statistical methods in medical research | | 2022 | 144 | 92 | ||
| Global epidemiology of rheumatoid arthritis | Nature reviews. Rheumatology | | 2022 | 349 | 1 | ||
| Robust T-Cell Responses in Anti-CD20 Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study | Clinical infectious diseases | | 2022 | 225 | 35 | ||
| Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration | Annals of the rheumatic diseases | | 2022 | 334 | 81 | ||
| Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases | Frontiers in immunology | | 2022 | 201 | 58 | ||
| Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis : a descriptive cohort study assessing trends in patient characteristics in Switzerland | BMJ open | | 2022 | 58 | 33 | ||
| Editoria : The interplay between the oral microbiota and rheumatoid arthritis | Frontiers in oral health | | 2022 | 106 | 46 | ||
| Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA on the severity of rheumatoid arthritis | Rheumatology | | 2021 | 374 | 405 | ||
| EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors | Annals of the Rheumatic Diseases | | 2021 | 240 | 676 | ||
| Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis | BMJ Open | | 2021 | 352 | 129 | ||
| Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients | Rheumatology advances in practice | | 2021 | 158 | 76 | ||
| Comparison of psoriatic arthritis and rheumatoid arthritis patients across body mass index categories in Switzerland | Journal of Clinical Medicine | | 2021 | 219 | 88 | ||
| Identification of biological pathways specific to phases preceding rheumatoid arthritis development through gene expression profiling | International Journal of Immunogenetics | | 2021 | 214 | 0 | ||
| Analysing and reporting of observational data: a systematic review informing the EULAR points to consider when analysing and reporting comparative effectiveness research with observational data in rheumatology | RMD open | | 2021 | 260 | 118 | ||
| Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort | Annals of the Rheumatic Diseases | | 2021 | 183 | 206 | ||
| Greater trochanteric pain syndrome: predicting who will respond to a local glucocorticoid injection | Scandinavian Journal of Rheumatology | | 2021 | 253 | 0 | ||
| Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis | Rheumatology | | 2021 | 259 | 0 | ||
| Primary and secondary non-response: in need of operational definitions in observational studies | Annals of the Rheumatic Diseases | | 2021 | 250 | 77 | ||
| Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries | Annals of the Rheumatic Diseases | | 2021 | 205 | 244 | ||
| The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries | Rheumatology | | 2021 | 240 | 0 | ||
| Mazzotti reaction: Ivermectin-associated polyarthritis after delayed scabies treatment. Case report and review of the literature | Thérapie | | 2021 | 1,162 | 1 | ||
| Cognitive-bias modification intervention to improve physical activity in patients following a rehabilitation programme: protocol for the randomised controlled IMPACT trial | BMJ open | | 2021 | 249 | 124 | ||
| Impact of assessing patient-reported outcomes with mobile apps on patient–provider interaction | RMD Open | | 2021 | 256 | 64 | ||
| Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab | RMD open | | 2021 | 259 | 90 | ||
| Personalized prediction of disease activity in patients with rheumatoid arthritis using an adaptive deep neural network | PLOS ONE | | 2021 | 291 | 161 | ||
| EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis | Annals of the Rheumatic Diseases | | 2021 | 372 | 91 | ||
| Is the prevention of rheumatoid arthritis possible? | Clinical Rheumatology | | 2020 | 174 | 0 | ||
| Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis | Arthritis Research and Therapy | | 2020 | 407 | 202 | ||
| EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases | Annals of the Rheumatic Diseases | | 2020 | 348 | 0 | ||
| Associations between gut microbiota and genetic risk for rheumatoid arthritis in the absence of disease: a cross-sectional study | The Lancet. Rheumatology | | 2020 | 240 | 189 | ||
| smarter medicine: liste Top-5 pour le traitement des rhumatismes | Bulletin des médecins suisses | | 2020 | 113 | 53 | ||
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update | Annals of the Rheumatic Diseases | | 2020 | 480 | 222 | ||
| Measuring ACPA in the general population or primary care: is it useful? | RMD Open | | 2020 | 235 | 151 | ||
| Mini-Review: Human Microbiome and Rheumatic Diseases | Frontiers in cellular and infection microbiology | | 2020 | 191 | 145 | ||
| Preferences for treatments to prevent rheumatoid arthritis in Canada and the influence of shared decision-making | Clinical Rheumatology | | 2020 | 203 | 0 | ||
| Predictive factors of treatment persistence in rheumatoid arthritis | Joint, Bone, Spine | | 2020 | 416 | 603 | ||
| Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland | RMD Open | | 2020 | 215 | 88 | ||
| Discordances between clinical and ultrasound measurements of disease activity among RA patients followed in real life | Joint, Bone, Spine | | 2020 | 357 | 0 | ||
| The role of nutritional factors and intestinal microbiota in rheumatoid arthritis development | Nutrients | | 2020 | 168 | 163 | ||
| Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the disease | Rheumatology | | 2020 | 321 | 8 | ||
| Periodontal status correlates with anti‐citrullinated protein antibodies in first‐degree relatives of individuals with rheumatoid arthritis | Journal of Clinical Periodontology | | 2019 | 420 | 2 | ||
| Presence of anti-cyclic citrullinated peptide antibodies is associated with better treatment response to abatacept but not to TNF inhibitors in patients with rheumatoid arthritis: a meta-analysis | Clinical and Experimental Rheumatology | | 2019 | 380 | 126 | ||
| Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution | Rheumatology | | 2019 | 370 | 0 | ||
| EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases | RMD Open | | 2019 | 333 | 173 | ||
| Imputing missing data of function and disease activity in rheumatoid arthritis registers: what is the best technique? | RMD Open | | 2019 | 333 | 137 | ||
| Menopause and possible effect on association between age and anticyclic citrullinated peptide antibodies in women at risk of rheumatoid arthritis | Journal of Rheumatology | | 2019 | 297 | 0 | ||
| Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three years | Rheumatology | | 2019 | 301 | 149 | ||
| Glucocorticoid injections for greater trochanteric pain syndrome: a randomised double-blind placebo-controlled (GLUTEAL) trial | Clinical Rheumatology | | 2019 | 313 | 0 | ||
| The links of hepcidin and erythropoietin in the interplay of inflammation and iron deficiency in a large observational study of rheumatoid arthritis | British Journal of Haematology | | 2019 | 255 | 0 | ||
| Role of reproductive and menopausal factors in functional and structural progression of rheumatoid arthritis: results from the SCQM cohort | Rheumatology | | 2019 | 265 | 0 | ||
| 2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis | Annals of the Rheumatic Diseases | | 2019 | 342 | 233 | ||
| Towards standardized patient reported physical function outcome reporting: linking ten commonly used questionnaires to a common metric | Quality of Life Research | | 2019 | 270 | 129 | ||
| Patients with rheumatoid arthritis facing sick leave or work disability meet varying regulations: a study among rheumatologists and patients from 44 European countries | Annals of the Rheumatic Diseases | | 2019 | 359 | 0 | ||
| Ultrasound is not associated with the presence of systemic autoimmunity or symptoms in individuals at risk for rheumatoid arthritis | RMD Open | | 2019 | 335 | 88 | ||
| Preventing rheumatoid arthritis: preferences for and predicted uptake of preventive treatments among high risk individuals | PLOS ONE | | 2019 | 305 | 197 | ||
| Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendations | RMD Open | | 2019 | 339 | 123 | ||
| Prevotella copri in individuals at risk for rheumatoid arthritis | Annals of the Rheumatic Diseases | 2019 | 464 | 0 | |||
| Preferences of Patients and At-risk Individuals for Preventive Approaches to Rheumatoid Arthritis | Clinical Therapeutics | | 2019 | 292 | 1 | ||
| Intestinal dysbiosis in RA development: difficulty of establishing causality. Response to: 'Non-causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study' by Inamo | Annals of the Rheumatic Diseases | | 2019 | 336 | 4 | ||
| Lessons learned from rheumatoid arthritis registries | Joint, Bone, Spine | | 2018 | 440 | 3 | ||
| Initial validation and results of the Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: a EULAR project | RMD Open | | 2018 | 461 | 181 | ||
| Workforce requirements in rheumatology: a systematic literature review informing the development of a workforce prediction risk of bias tool and the EULAR points to consider | RMD Open | | 2018 | 313 | 184 | ||
| EULAR 'points to consider' for the conduction of workforce requirement studies in rheumatology | RMD Open | | 2018 | 316 | 183 | ||
| Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort | Journal of Rheumatology | | 2018 | 457 | 1 | ||
| Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid Arthritis | Medical Decision Making | | 2018 | 473 | 0 | ||
| 2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis | Annals of the Rheumatic Diseases | | 2018 | 426 | 0 | ||
| Microbiotes et rhumatismes inflammatoires | Revue médicale suisse | | 2018 | 498 | 146 | ||
| Chagas disease and systemic autoimmune diseases among Bolivian patients in Switzerland | Memórias do Instituto Oswaldo Cruz | | 2018 | 596 | 196 | ||
| Low Hemoglobin and Radiographic Damage Progression in Early Rheumatoid Arthritis: Secondary Analysis From a Phase III Trial | Arthritis Care and Research | | 2018 | 365 | 1 | ||
| Incidence and prevalence of major adverse cardiovascular events in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis | Arthritis Care and Research | | 2018 | 433 | 399 | ||
| Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis | Rheumatology | | 2017 | 541 | 5 | ||
| Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers | Annals of the Rheumatic Diseases | | 2017 | 499 | 219 | ||
| Value of Biomarkers in the Prevention of Rheumatoid Arthritis | Clinical Pharmacology and Therapeutics | | 2017 | 453 | 0 | ||
| The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis | Clinical Rheumatology | | 2017 | 625 | 3 | ||
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update | Annals of the Rheumatic Diseases | | 2017 | 479 | 2 | ||
| Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM) | Clinical Rheumatology | | 2017 | 404 | 0 | ||
| Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype | PloS one | | 2017 | 557 | 249 | ||
| Environmental factors and hormones in the development of rheumatoid arthritis | Seminars in Immunopathology | | 2017 | 477 | 0 | ||
| Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA) | Clinical Rheumatology | | 2017 | 479 | 2 | ||
| The role of female hormonal factors in the development of rheumatoid arthritis | Rheumatology | | 2017 | 460 | 0 | ||
| Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life | Quality of life research | | 2017 | 520 | 1 | ||
| New viral outbreaks: time for rheumatologists to get involved? | Rheumatology | | 2017 | 460 | 0 | ||
| Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis | Annals of the rheumatic diseases | | 2016 | 590 | 0 | ||
| The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis | Arthritis & rheumatology | | 2016 | 526 | 0 | ||
| Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative | Annals of the Rheumatic Diseases | | 2016 | 453 | 0 | ||
| Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary Report | The New England journal of medicine | | 2016 | 917 | 266 | ||
| Low pre-treatment B-cell counts are not a risk factor of infection in patients treated with rituximab for autoimmune diseases: An observational study | Joint, Bone, Spine | | 2016 | 533 | 0 | ||
| Preventive Treatments for Rheumatoid Arthritis: Issues Regarding Patient Preferences | Current rheumatology reports | | 2016 | 559 | 1 | ||
| Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis | Arthritis and Rheumatology | | 2016 | 380 | 0 | ||
| Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study | EBioMedicine | | 2016 | 480 | 194 | ||
| Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-Analysis | Journal of managed care & specialty pharmacy | | 2015 | 586 | 0 | ||
| Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry | Rheumatology | | 2015 | 495 | 0 | ||
| The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers | Rheumatology | | 2015 | 595 | 285 | ||
| The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial | Lancet. Infectious diseases | | 2015 | 701 | 0 | ||
| The new 2010 ACR/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis | Clinical rheumatology | | 2015 | 563 | 0 | ||
| An Internet-based technique for the identification of persons with symptoms of inflammatory polyarthritis of less than 12 weeks | Clinical rheumatology | | 2015 | 469 | 0 | ||
| Anti-tumor necrosis factor drug survival in axial spondyloarthritis is independent of the classification criteria | Rheumatology international | | 2015 | 597 | 0 | ||
| Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study | Annals of the rheumatic diseases | | 2015 | 643 | 0 | ||
| Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study | Annals of the rheumatic diseases | | 2015 | 564 | 298 | ||
| The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries | RMD open | | 2015 | 480 | 239 | ||
| Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study | Inflammatory bowel diseases | | 2015 | 490 | 0 | ||
| The impact of obesity on the development and progression of rheumatoid arthritis | Annals of the rheumatic diseases | | 2014 | 556 | 0 | ||
| Immune-mediated experimental arthritis in IL-33 deficient mice | Cytokine | | 2014 | 671 | 0 | ||
| Prevention of rheumatic diseases: strategies, caveats, and future directions | Rheumatic diseases clinics of North America | 2014 | 490 | 0 | |||
| Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee | International orthopaedics | | 2014 | 575 | 0 | ||
| Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK | PharmacoEconomics | | 2014 | 521 | 478 | ||
| Joint damage progression in patients with rheumatoid arthritis in clinical remission. Do biologics perform better than synthetic antirheumatic drugs? | Journal of rheumatology | | 2014 | 523 | 0 | ||
| Facteurs de risque pour le développement d'une polyarthrite rhumatoïde | Revue médicale suisse | | 2014 | 530 | 2 | ||
| Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study | Annals of the rheumatic diseases | | 2014 | 613 | 591 | ||
| Persistence of ultrasound synovitis in patients with rheumatoid arthritis fulfilling the DAS28 and/or the new ACR/EULAR RA remission definitions: results of an observational cohort study | Joint bone spine | | 2014 | 590 | 0 | ||
| Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial | Arthritis research & therapy | | 2014 | 703 | 215 | ||
| Complications cardio-vasculaires dans les maladies auto-immunes | Revue médicale suisse | | 2013 | 544 | 1 | ||
| Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registry | Joint bone spine | | 2013 | 557 | 0 | ||
| Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency | Arthritis research & therapy | | 2013 | 641 | 262 | ||
| Primary prevention of rheumatoid arthritis: a qualitative study in a high-risk population | Joint bone spine | | 2013 | 621 | 1 | ||
| Do synovial leptin levels correlate with pain in end stage arthritis? | International orthopaedics | | 2013 | 670 | 184 | ||
| Smoking and spondyloarthritis | Joint bone spine | | 2013 | 557 | 1 | ||
| The importance of early treatment for the prognosis of rheumatoid arthritis | Schweizerische medizinische Wochenschrift | | 2013 | 654 | 292 | ||
| Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial | Annals of the rheumatic diseases | | 2012 | 670 | 0 | ||
| Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists | Annals of the rheumatic diseases | | 2012 | 557 | 406 | ||
| Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores? | Arthritis care & research | | 2012 | 692 | 0 | ||
| Pain as an important predictor of psychosocial health in patients with rheumatoid arthritis | Arthritis care & research |  | 2012 | 657 | 0 | ||
| EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis | Annals of the rheumatic diseases | | 2012 | 697 | 563 | ||
| Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients | Annals of the rheumatic diseases | | 2012 | 676 | 0 | ||
| Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infection | Microbes and infection | | 2011 | 615 | 0 | ||
| Patient repositioning reproducibility of joint space with (JSW) measurements on hand radiographs | Arthritis care & research | | 2011 | 480 | 0 | ||
| Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center | Arthritis and rheumatism | | 2011 | 682 | 0 | ||
| The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study | Rheumatology | | 2011 | 605 | 0 | ||
| Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis | Arthritis and rheumatism | | 2011 | 643 | 0 | ||
| Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion | Rheumatology | | 2011 | 507 | 0 | ||
| Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis | Annals of the rheumatic diseases | | 2011 | 582 | 0 | ||
| EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology | Annals of the rheumatic diseases | | 2010 | 587 | 0 | ||
| Osteoarthritis: Small studies overestimate the benefit of therapies for OA | Nature reviews. Rheumatology | | 2010 | 684 | 0 | ||
| Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients | Joint bone spine | | 2010 | 611 | 0 | ||
| Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients | Arthritis research & therapy | | 2010 | 780 | 529 | ||
| Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis | Arthritis and rheumatism | | 2010 | 899 | 3 | ||
| Cost-effectiveness of biologics in early rheumatoid arthritis | Annals of internal medicine | 2010 | 517 | 0 | |||
| The effect of alcohol on radiographic progression in rheumatoid arthritis | Arthritis and rheumatism | | 2010 | 591 | 0 | ||
| Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? | Annals of the rheumatic diseases | | 2010 | 589 | 0 | ||
| Comparative effectiveness of rheumatoid arthritis therapies | Current rheumatology reports | | 2010 | 516 | 0 | ||
| Swiss consensus statement: Recommendations for optimising re-treatment with MabThera (rituximab) in rheumatoid arthritis | Schweizerische medizinische Wochenschrift | 2010 | 566 | 0 | |||
| A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries | Seminars in arthritis and rheumatism | | 2010 | 626 | 0 | ||
| Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trial | Arthritis and rheumatism | | 2010 | 669 | 0 | ||
| Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis | Arthritis and rheumatism | | 2009 | 654 | 0 | ||
| Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies | Schweizerische medizinische Wochenschrift | | 2009 | 625 | 309 | ||
| Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis | Arthritis and rheumatism | | 2009 | 603 | 0 | ||
| BMI and severity of clinical and radiographic signs of hip osteoarthritis | Obesity | | 2009 | 980 | 0 | ||
| Influence of cytokine inhibitors on concentration and activity of MMP-1 and MMP-3 in disc herniation | Arthritis research & therapy | | 2009 | 657 | 227 | ||
| The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study | Annals of the rheumatic diseases | | 2009 | 605 | 0 | ||
| Elevated levels of tumor necrosis factor-alpha in periradicular fat tissue in patients with radiculopathy from herniated disc | Spine | | 2008 | 673 | 0 | ||
| At the horizon of innovative therapy in rheumatology: new biologic agents | Current opinion in rheumatology | | 2008 | 621 | 0 | ||
| Primer: strengths and weaknesses of meta-analysis | Nature clinical practice rheumatology | | 2008 | 662 | 0 | ||
| Neutral functional realignment orthosis prevents hand pain in patients with subacute stroke: a randomized trial | Archives of physical medicine and rehabilitation | | 2008 | 599 | 0 | ||
| B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents | Arthritis and rheumatism | | 2007 | 177 | 1 | ||
| Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women | Arthritis and rheumatism | | 2006 | 240 | 403 | ||
| Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management | Annals of the rheumatic diseases | | 2004 | 507 | 2 | ||
| Neurophysiologic evidence for a central sensitization in patients with fibromyalgia | Arthritis and rheumatism | | 2003 | 538 | 788 |
